Koyfin Home > Directory > Health Care > Abbott Laboratories > Cash Acquisitions

Abbott Laboratories Cash Acquisitions Chart (ABT)

Abbott Laboratories annual/quarterly Cash Acquisitions from 2010 to 2020.
  • Abbott Laboratories Cash Acquisitions for the quarter ending September 09, 2020 was $0m a 0.00% increase of 11m year over year
  • Abbott Laboratories Cash Acquisitions for the last 12 months ending September 09, 2020 was $-31m a -448.39% increase of 139m year over year
  • Abbott Laboratories Annual Cash Acquisitions for 2019 was $-170m a 68.24% decrease of -116m from 2018
  • Abbott Laboratories Annual Cash Acquisitions for 2018 was $-54m a -31,720.37% increase of 17,129m from 2017
  • Abbott Laboratories Annual Cash Acquisitions for 2017 was $-17,183m a 99.53% decrease of -17,103m from 2016
Other Cash Flow Metrics:
  • Abbott Laboratories Cash Flow from Operations for the quarter ending September 09, 2018 was $2,183m a 8.15% increase of 178m year over year
  • Abbott Laboratories Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $1,647m a 6.17% increase of 102m year over year
  • Abbott Laboratories Total Revenue for the quarter ending December 12, 2018 was $7,765m a 4.83% increase of 375m year over year
View Chart On Koyfin

Quarterly ABT Cash Acquisitions Data

09/2020$0m
06/2020$-32m
12/2019$1m
09/2019$-11m
06/2019$-82m
03/2019$-78m
12/2018$-11m
09/2018$0m
06/2018$-18m
03/2018$-25m

Annual ABT Cash Acquisitions Data

2019$-170m
2018$-54m
2017$-17,183m
2016$-80m
2015$-235m
2014$-3,317m
2013$-580m
2012$-706m
2011$-273m
2010$-9,433m